Lymphoma patient study for people living near Malawi’s main hospital
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This is a study that enrolls people with suspected or confirmed lymphoma who come to Kamuzu Central Hospital. It aims to collect lymphoma information (including optional genetic testing of tumor samples) to better understand the disease in Malawi.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were referred to Kamuzu Central Hospital because a clinician suspects lymphoma
- You are older than 5 years, or if 5 or younger, lymphoma must already be confirmed by a tissue/pathology test
- You have no history of other confirmed cancers and you have not received cancer treatment for a previous cancer
- You live within 200 kilometers of Kamuzu Central Hospital
- You (or your parent/guardian) can understand the study and sign consent in English or Chichewa
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for adults newly diagnosed with lymphoma in the last 3 months, including those who may have started treatment. It aims to collect information on patients in Italy.
This study collects family and medical history to better understand inherited causes of blood cancers (like lymphoma) and related conditions. It may help researchers build genetic findings that could improve how families understand their risk and future care.
This study tracks people newly diagnosed with non-Hodgkin lymphoma to learn more about the disease and how treatments work. It helps doctors improve future care by collecting real-world data.
This study helps people navigate the steps of joining a clinical trial for lymphoma. It aims to make the process clearer and more accessible for patients.
This study tests a treatment plan for children under 18 with a new diagnosis of acute myeloid leukemia (AML). It aims to provide effective therapy based on standard guidelines, and may include children with certain blood or bone marrow findings even if tests are limited.
This study collects leftover tissue samples from patients with or without lymphoma to help researchers better understand lymph system cancers. It may be an option if you are already having a biopsy or surgery.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.